Physician profile
John W Forrest
NPI 1083635726
$852.29
in general payments reported to CMS, 2019-2025
9 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.38 · 2020: $23.34 · 2021: $204 · 2022: $228 · 2023: $189 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $469.93 | 2021-2023 | Cequa |
| Alcon Vision LLC | $198.44 | 2019-2025 | Unity, Lensx |
| Abbvie INC. | $50.91 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $37.55 | 2019-2020 | |
| Allergan, INC. | $30.46 | 2021 | |
| Bausch & Lomb Americas INC. | $19.53 | 2023 | Prolensa, Vyzulta, Lotemax Sm |
| Lensar, INC. | $18.08 | 2023 | Lensar Laser System |
| Horizon Therapeutics Plc | $14.36 | 2023 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $13.03 | 2023 | Iolmaster 700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Forrest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.